Schmitz-Peiffer C, Browne C L, Biden T J
Garvan Institute of Medical Research, St. Vincent's Hospital, Darlinghurst, Australia.
Biochem J. 1996 Nov 15;320 ( Pt 1)(Pt 1):207-14. doi: 10.1042/bj3200207.
We have investigated protein kinase C (PKC) in skeletal muscle cytosol and demonstrated the presence of two major activities. These did not correspond to different PKC isoenzymes but seemed to represent two species of PKC alpha as deduced by: elution during hydroxyapatite chromatography at KH2PO4 concentrations expected of PKC alpha; detection of the two species by three specific but unrelated anti-(PKC alpha) antibodies; immunodepletion of both activities with anti-(PKC alpha) antibody; and demonstration of identical requirements of both Ca2+ ions and lipid for activation. These species, termed PKC alpha 1 and PKC alpha 2, phosphorylated the modified conventional PKC pseudosubstrate peptide (19-31, Ser-25) equally well. Importantly, however, the activities differed in that PKC alpha 1 phosphorylated histone IIIS, and also peptides derived from the EGF receptor and glycogen synthase, to a much greater extent than did PKC alpha 2. Similarly, incubation of crude muscle extracts with either PKC alpha 1 or alpha 2 gave rise to different protein phosphorylation patterns. The involvement of proteolysis, dephosphorylation or oxidative modification in the interconversion of PKC alpha 1 and PKC alpha 2 during preparation was ruled out. Although some PKC-binding proteins were detected in overlay assays, their presence did not explain the anomalous PKC alpha 2 activity. The results suggest that a modification of PKC alpha in situ limits its substrate specificity, and indicate an additional level of control of the kinase that may be a site for modulation of PKC-mediated signal transduction.
我们研究了骨骼肌胞质溶胶中的蛋白激酶C(PKC),并证实存在两种主要活性。这些活性并不对应于不同的PKC同工酶,而是似乎代表两种PKCα,这是通过以下方式推断的:在KH2PO4浓度下进行羟基磷灰石色谱洗脱,该浓度是PKCα预期的;用三种特异性但不相关的抗(PKCα)抗体检测到这两种物质;用抗(PKCα)抗体对两种活性进行免疫去除;以及证明两种物质对Ca2+离子和脂质的激活具有相同的需求。这些物质被称为PKCα1和PKCα2,它们对修饰的传统PKC假底物肽(19 - 31,Ser - 25)的磷酸化效果相同。然而,重要的是,这两种活性有所不同,PKCα1对组蛋白IIIS以及源自表皮生长因子受体和糖原合酶的肽的磷酸化程度比PKCα2大得多。同样,用PKCα1或α2孵育粗肌肉提取物会产生不同的蛋白质磷酸化模式。在制备过程中,PKCα1和PKCα2相互转化过程中蛋白水解、去磷酸化或氧化修饰的参与被排除。尽管在覆盖分析中检测到了一些PKC结合蛋白,但它们的存在并不能解释PKCα2的异常活性。结果表明,原位PKCα的修饰限制了其底物特异性,并表明激酶存在额外的控制水平,这可能是调节PKC介导的信号转导的一个位点。